Litigation for QTERNMET XR

US Court Litigation for QTERNMET XR

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
6,414,126			2018-05-01	2022-07-28	35:271 Patent Infringement	District Court, D. Delaware	None
6,414,126			2017-07-07		15:1126 Patent Infringement	District Court, D. New Jersey	None
6,414,126	MITSUBISHI TANABE PHARMA CORPORATION v. SANDOZ INC.		2017-07-20	2021-04-05	15:1126 Patent Infringement	District Court, D. New Jersey	None
6,414,126	MITSUBISHI TANABE PHARMA CORPORATION v. LUPIN LIMITED		2018-01-08		15:1126 Patent Infringement	District Court, D. New Jersey	None
6,515,117			2018-05-01	2022-07-28	35:271 Patent Infringement	District Court, D. Delaware	None
6,515,117			2017-07-07		15:1126 Patent Infringement	District Court, D. New Jersey	None
6,515,117	MITSUBISHI TANABE PHARMA CORPORATION v. SANDOZ INC.		2017-07-20	2021-04-05	15:1126 Patent Infringement	District Court, D. New Jersey	None

Patent Trial and Appeal Board Cases for QTERNMET XR

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
RE44,186	Mylan Pharmaceuticals Inc.		2015-06-04	06-04-2015	AstraZeneca AB	Inter partes review		05-02-2016	Jeffrey Robl
RE44,186	Wockhardt Bio AG		2016-05-11	05-11-2016	AstraZeneca AB	Inter partes review		08-23-2016	Jeffrey Robl
RE44,186	Amneal Pharmaceuticals LLC		2016-06-01	06-03-2016	AstraZeneca AB	Inter partes review		11-22-2016	Jeffrey Robl
RE44,186	Aurobindo Pharma U.S.A., Inc.		2016-06-02	06-02-2016	ASTRAZENECA AB	Inter partes review		10-21-2016	Jeffrey Robl
RE44,186	Teva Pharmaceuticals USA Inc.		2016-06-01	06-01-2016	AstraZeneca AB	Inter partes review		09-23-2016	Jeffrey Robl